References
- Franchini M, Vaglio S, Marano G, Mengoli C, Gentili S, Pupella S, Liumbruno GM. Acquired hemophilia A: a review of recent data and new therapeutic options. Hematology 2017;22:514–520. doi:https://doi.org/10.1080/10245332.2017.1319115.
- Collins P, Baudo F, Huth-Kühne A, Ingerslev J, Kessler CM, Castellano MEM, Shima M, St-Louis J, Lévesque H. Consensus recommendations for the diagnosis and treatment of acquired hemophilia A. BMC Res Notes 2010;3:161. doi:https://doi.org/10.1186/1756-0500-3-161.
- Kruse-Jarres R, Kempton CL, Baudo F, Collins PW, Knoebl P, Leissinger CA, Tiede A. Kessler CM Acquired hemophilia A: updated review of evidence and treatment guidance. Am J Hematol 2017;92:695–705. doi:https://doi.org/10.1002/ajh.24777.
- Menegatti M, Biguzzi E, Peyvandi F. Management of rare acquired bleeding disorders. Hematology Am Soc Hematol Educ Program 2019;6:80–87. doi:https://doi.org/10.1182/hematology.2019000066.
- Pareti FI, Gugliotta L, Mannucci L, Guarini A, Mannucci PM. Biochemical and metabolic aspects of platelet dysfunction in chronic myeloproliferative disorders. Thromb Haemost 1982 Apr 30;47(2):84–89. PMID: 7101243. doi:https://doi.org/10.1055/s-0038-1657135.
- Manoharan A, Brighton T, Gemmell R, Lopez K, Moran S, Kyle P. Platelet dysfunction in myelodysplastic syndromes: a clinicopathological study. Int J Hematol 2002;76:272–278. doi:https://doi.org/10.1007/BF02982798.
- Raman V, Quillen K, Sloan JM. Acquired Glanzmann thrombasthenia associated with Hodgkin lymphoma: rapid reversal of functional platelet defect with ABVD (adriamycin/bleomycin/vinblastine/dacarbazine) chemotherapy. Clin Lymphoma Myeloma Leuk 2014;14:e51–e54. doi:https://doi.org/10.1016/j.clml.2013.10.004.
- Cattaneo M, Cerletti C, Harrison P, Hayward CP, Kenny D, Nugent D, Nurden P, Rao AK, Schmaier AH, Watson SP, et al. Recommendations for the standardization of light transmission aggregometry: A consensus of the working party from the platelet physiology subcommittee of ssc/isth. J Thromb Haemost 2013;11:1183–1186. doi:https://doi.org/10.1111/jth.12231.
- Cattaneo M, Lecchi A, Lombardi R, Gachet C. Zighetti ML: platelets from a patient heterozygous for the defect of p2cyc receptors for ADP have a secretion defect despite normal thromboxane a2 production and normal granule stores: further evidence that some cases of platelet ‘primary secretion defect’ are heterozygous for a defect of p2cyc receptors. Arterioscler Thromb Vasc Biol 2000;20:E101–106. doi:https://doi.org/10.1161/01.atv.20.11.e101.
- Jedlitschky G, Cattaneo M, Lubenow LE, Rosskopf D, Lecchi A, Artoni A, Motta G, Niessen J, Kroemer HK, Greinacher A. Role of MRP4 (ABCC4) in platelet adenine nucleotide-storage: evidence from patients with delta-storage pool deficiencies. Am J Pathol 2010;176:1097–1103. doi:https://doi.org/10.2353/ajpath.2010.090425.
- Lecchi A, La Marca S, Femia EA, Lenz A, Boeckelmann D, Artoni A, Peyvandi F, Zieger B. Novel variant in HPS3 gene in a patient with Hermansky Pudlak syndrome (HPS) type 3 Platelets. Platelets 2020 Oct 2;31(7):960–963. doi:https://doi.org/10.1080/09537104.2019.1704716.
- Le Cam-Duchez V. Acquired hemophilia A and lymphoproliferative diseases: a literature review. Rev Med Interne 2015;36:834–839. doi:https://doi.org/10.1016/j.revmed.2015.09.004.
- Kruse-Jarres R, St-Louis J, Greist A, Shapiro A, Smith H, Chowdary P, Drebes A, Gomperts E, Bourgeois C, Mo M, et al. Efficacy and safety of OBI-1, an antihaemophilic Factor VIII (Recombinant), porcine sequence, in subjects with acquired haemophilia. A Haemophilia 2015;21:162–170. .doi:https://doi.org/10.1111/hae.12627.
- Stemberger M, Mohnle P, Tschop J, Ney L, Spannagl M, Reincke M. Successful bleeding control with recombinant porcine factor VIII in reduced loading doses in two patients with acquired haemophilia A and failure of bypassing agent therapy. Haemophilia 2016;22:472–474. doi:https://doi.org/10.1111/hae.13046.
- Zhou J, Wu M, Peng Z, Zhao WH, Bai ZJ. Clinical analysis of 20 patients with non-Hodgkin lymphoma and autoimmune hemolytic anemia. A retrospective study. Medicine (Baltimore) 2020;99:e19015. doi:https://doi.org/10.1097/MD.0000000000019015.
- Schuh AH, Parry-Jones N, Appleby N, Bloor A, Dearden CE, Fegan C, Follows G, Fox CP, Iyengar S, Kennedy B, et al. Guideline for the treatment of chronic lymphocytic leukaemia: a British Society for Haematology Guideline. Br J Haematol 2018;182:344–359. .doi:https://doi.org/10.1111/bjh.15460.
- Cohen Y, Polliack A, Zelig O, Goldfarb A. Monotherapy with rituximab induces rapid remission of recurrent cold agglutinin-mediated hemolytic anemia in a patient with indolent lympho-plasmacytic lymphoma. Leuk Lymphoma 2001;42:1405–1408. doi:https://doi.org/10.3109/10428190109097770.
- Reda G, Cassin R, Artoni FB, Lecchi A, La Marca S, Bucciarelli P, Levati GV, Peyvandi F, Cortelezzi A. Idelalisib rapidly improves platelet function tests in patients with chronic lymphocytic leukaemia. Br J Haematol 2018;183:825–828. doi:https://doi.org/10.1111/bjh.15052.
- Hauswirth AW, Skrabs C, Schützinger C, Raderer M, Chott A, Valent P, Lechner K, Jäger U. Autoimmune thrombocytopenia in non-Hodgkin’s lymphomas. Haematologica 2008;93:447–450. doi:https://doi.org/10.3324/haematol.11934.
- Luu S, Gardiner E, Andrews RK. Bone marrow defects and platelet function: A Focus on MDS and CLL, Cancers (Basel). Cancers 2018;10:147. doi:https://doi.org/10.3390/cancers10050147.